For quantitative analysis, mixtures of lysed NSCLC cell lines (mutant and WT EGFR), resulting in an estimated LOD of 1% and 0.1% for the cell populations harboring the E746_A750 and L858R substitutions, respectively. This evidence concerns the gene EGFR and non-small cell lung carcinoma.